Veronika Karpina

Ms. Veronika Karpina

Junior research scientist
orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 September 2020 in Molecules
Verified
Journal Article
Open access
PDF file
Veronika KarpinaVeronika Karpina
Veronika Karpina
SKSvitlana S. Kovalenko
Svitlana S. Kovalenko
Sergiy M. KovalenkoSergiy M. Kovalenko
Sergiy M. Kovalenko
ODOleksandr Drushlyak
Oleksandr Drushlyak
NBNatalya D. Bunyatyan
Natalya D. Bunyatyan
LMLouis Maes
Louis Maes
For the development of new and potent antimalarial drugs, we designed the virtual library with three points of randomization of novel [1,2,4]triazolo[4,3-a]pyridines bearing a sulfonamide fragment. The library of 1561 compounds has been investigated by both virtual screening and molecular docking methods using falcipain-2 as a target enzyme. 25 chosen hits were synthesized and evaluated for their antimalarial activity in vitro against Plasmodium falciparum. 3-Ethyl-N-(3-fluorobenzyl)-N-(4-methoxyphenyl)-[1,2,4]triazolo[4,3-a]pyridine-6-sulfonamide and 2-(3-chlorobenzyl)-8-(piperidin-1-ylsulfonyl)-[1,2,4]triazolo[4,3-a]pyridin-3(2H)-one showed in vitro good antimalarial activity with inhibitory concentration IC50 = 2.24 and 4.98 μM, respectively. This new series of compounds may serve as a starting point for future antimalarial drug discovery programs.

30 July 2020 in Acta Crystallographica Section C Structural Chemistry
Verified
Journal Article
Closed access
PDF file
SSSvitlana Shishkina
Svitlana Shishkina
IKIrina Konovalova
Irina Konovalova
Veronika KarpinaVeronika Karpina
Veronika Karpina
Sergiy M. KovalenkoSergiy M. Kovalenko
Sergiy M. Kovalenko
Sergiy M. KovalenkoSergiy M. Kovalenko
Sergiy M. Kovalenko
NBNatalya D Bunyatyan
Natalya D Bunyatyan